February 20, 2024
3 min watch
Save
VIDEO: Phakic IOLs a ‘go-to’ for patients with low to moderate myopia
Issue: March 25, 2024
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
TAMPA, Fla. — In this Healio Video Perspective from Telling It Like It Is, Elizabeth Yeu, MD, FACS, discusses why she recommends the EVO ICL to treat patients with low to moderate myopia.
“This is an additive, not subtractive, surgery, with optimum quality of vision that will not affect [patients’] postoperative outcomes or limit their cataract surgery IOL options in the future,” she said.
Yeu especially recommends using the EVO ICL (STAAR Surgical) in patients who may have previously been considered for PRK.
Published by:
Sources/Disclosures
Collapse
Source:
Yeu E. Phakic IOLs as a first choice for low and moderate myopes. Presented at: Telling It Like It Is; Feb. 15-18, 2024; Tampa, Florida.
Disclosures:
Yeu reports consulting for STAAR Surgical.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.